We are live on ! Find out more
ACIU icon

AC Immune
ACIU

37 hedge funds and large institutions have $30.1M invested in AC Immune in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

9% more funds holding

Funds holding: 34 → 37 (+3)

0.89% more ownership

Funds ownership: 16.78% → 17.67% (+0.89%)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

32% less capital invested

Capital invested by funds: $44.3M → $30.1M (-$14.2M)

66% less call options, than puts

Call options by funds: $12K | Put options by funds: $35K

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
9
Closed
5
Calls
$12K
Puts
$35K
Net Calls
-$23K
Net Calls Change
-$48K

Top Buyers

Rank Fund Capital Flow
1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.53M
2
Citadel Advisors
Citadel Advisors
Florida
+$431K
3
Millennium Management
Millennium Management
New York
+$280K
4
Wells Fargo
Wells Fargo
California
+$202K
5
E
Ergoteles
New York
+$187K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$938K
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$82K
3
Renaissance Technologies
Renaissance Technologies
New York
-$77.8K
4
Morgan Stanley
Morgan Stanley
New York
-$68.9K
5
Deutsche Bank
Deutsche Bank
Germany
-$63.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$15.2M – – –
Morgan Stanley
2
Morgan Stanley
New York
$3.98M -$68.9K -26,730 -1%
PIM
3
Platinum Investment Management
Australia
$2.21M +$59.3K +23,000 +2%
AG
4
Artal Group
Luxembourg
$2.04M – – –
Wells Fargo
5
Wells Fargo
California
$1.49M +$202K +78,366 +12%
Assenagon Asset Management
6
Assenagon Asset Management
Luxembourg
$1.21M +$1.53M +592,044 New
Renaissance Technologies
7
Renaissance Technologies
New York
$826K -$77.8K -30,200 -7%
APM
8
Avidity Partners Management
Texas
$664K +$130K +50,524 +18%
Deutsche Bank
9
Deutsche Bank
Germany
$529K -$63.3K -24,568 -9%
Citadel Advisors
10
Citadel Advisors
Florida
$341K +$431K +167,063 New
EP
11
Eversept Partners
New York
$254K – – –
Millennium Management
12
Millennium Management
New York
$222K +$280K +108,806 New
Handelsbanken Fonder
13
Handelsbanken Fonder
Sweden
$206K – – –
E
14
Ergoteles
New York
$148K +$187K +72,632 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$122K +$154K +59,916 New
State Street
16
State Street
Massachusetts
$121K +$657 +255 +0.4%
UBS Group
17
UBS Group
Switzerland
$87.5K -$33.5K -12,992 -23%
Jane Street
18
Jane Street
New York
$86.9K +$110K +42,581 New
BCV
19
Banque Cantonale Vaudoise
Switzerland
$86K +$52.7K +20,432 +93%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$75K – – –
VF
21
Virtu Financial
New York
$72K +$91.5K +35,501 New
CSS
22
Cubist Systematic Strategies
Connecticut
$43.6K +$55.1K +21,384 New
Goldman Sachs
23
Goldman Sachs
New York
$38.5K -$19.9K -7,710 -29%
Mariner
24
Mariner
Kansas
$31K -$12.6K -4,869 -24%
LBC
25
Lawrence B. Cohen
$26.2K – – –
1
2

ACIU Hedge Fund Activity: Q4 2022 in Review

37 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2022, worth a combined $30.1M — down 32% from $44.3M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ACIU positions and 5 closed out — a net gain of 4 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $1.53M. The largest seller was BlackRock, cutting an estimated $938K.

  • 37 institutional investors held AC Immune (ACIU) as of Q4 2022, up from 34 in Q3 2022.
  • Funds reported $30.1M of AC Immune stock for Q4 2022, down 32% quarter-over-quarter.
  • 9 funds opened new AC Immune positions in Q4 2022 and 5 closed out, a net change of +4 holders.
  • The largest AC Immune buyer in Q4 2022 was Assenagon Asset Management, an estimated $1.53M added.
  • The largest AC Immune seller in Q4 2022 was BlackRock, an estimated $938K sold.

Based on aggregated 13F filings for Q4 2022.